These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 26617774)
1. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome. Wang X; Du Z; Li L; Shi M; Yu Y Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer. Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222 [TBL] [Abstract][Full Text] [Related]
3. Decreased Beclin-1 expression is correlated with the growth of the primary tumor in patients with squamous cell carcinoma and adenocarcinoma of the lung. Won KY; Kim GY; Lim SJ; Kim YW Hum Pathol; 2012 Jan; 43(1):62-8. PubMed ID: 21777947 [TBL] [Abstract][Full Text] [Related]
4. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis. Zhang Y; Ma M; Han B Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer. Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer. Jian M; Yunjia Z; Zhiying D; Yanduo J; Guocheng J Mol Carcinog; 2019 Mar; 58(3):358-365. PubMed ID: 30362635 [TBL] [Abstract][Full Text] [Related]
8. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer. Zhang J; Chen N; Qi J; Zhou B; Qiu X J Cancer Res Clin Oncol; 2014 Aug; 140(8):1441-9. PubMed ID: 24770635 [TBL] [Abstract][Full Text] [Related]
9. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer. Xu XY; Lin N; Li YM; Zhi C; Shen H Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781 [TBL] [Abstract][Full Text] [Related]
11. High TBX2 expression predicts poor prognosis in non-small cell lung cancer. Zhang Z; Guo Y Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744 [TBL] [Abstract][Full Text] [Related]
12. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Choi J; Jung W; Koo JS Histopathology; 2013 Jan; 62(2):275-86. PubMed ID: 23134379 [TBL] [Abstract][Full Text] [Related]
13. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Sakakura K; Takahashi H; Kaira K; Toyoda M; Oyama T; Chikamatsu K Cancer Sci; 2015 Jan; 106(1):1-8. PubMed ID: 25338734 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancer. Kim NY; Pyo JS Pathol Res Pract; 2017 Jul; 213(7):778-782. PubMed ID: 28554757 [TBL] [Abstract][Full Text] [Related]
16. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry. Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study. Li H; Zhou RJ; Zhang GQ; Xu JP Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668 [TBL] [Abstract][Full Text] [Related]
18. Analysis of MAT3 gene expression in NSCLC. Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Park JM; Huang S; Wu TT; Foster NR; Sinicrope FA Cancer Biol Ther; 2013 Feb; 14(2):100-7. PubMed ID: 23192274 [TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer. Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]